usamicro_0048|PHAS|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
usamicro_0048|PHAS|Long Name|1|1|PhaseBio Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Inventories (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Book Value (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc EV to Revenues|PhaseBio Pharmaceuticals Inc EV to Earnings|PhaseBio Pharmaceuticals Inc EV to Free Cash Flow|PhaseBio Pharmaceuticals Inc EV to Assets (Quarterly)|PhaseBio Pharmaceuticals Inc PS Ratio|PhaseBio Pharmaceuticals Inc PE Ratio|PhaseBio Pharmaceuticals Inc Price to Book Value|PhaseBio Pharmaceuticals Inc PEG Ratio|PhaseBio Pharmaceuticals Inc Debt to Equity Ratio|PhaseBio Pharmaceuticals Inc Dividend Yield|PhaseBio Pharmaceuticals Inc Shareholder Yield (TTM)|PhaseBio Pharmaceuticals Inc Percent of Shares Outstanding Short|PhaseBio Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Payables (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Return on Invested Capital|PhaseBio Pharmaceuticals Inc Quality Ratio Score|PhaseBio Pharmaceuticals Inc Momentum Score|PhaseBio Pharmaceuticals Inc Beta (1Y)|PhaseBio Pharmaceuticals Inc Sustainable Growth Rate (TTM)|PhaseBio Pharmaceuticals Inc Institutional Investor Ownership Percentage|PhaseBio Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|PhaseBio Pharmaceuticals Inc Total Employees (Annual)|PhaseBio Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Shares Outstanding|PhaseBio Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|PhaseBio Pharmaceuticals Inc Payout Ratio|PhaseBio Pharmaceuticals Inc Quick Ratio (Quarterly)|PhaseBio Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Effective Tax Rate (TTM)|PhaseBio Pharmaceuticals Inc Return on Equity|PhaseBio Pharmaceuticals Inc Net Income (TTM) (USD)|PhaseBio Pharmaceuticals Inc Revenue (TTM) (USD)|PhaseBio Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Revenue (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Net Income (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|PhaseBio Pharmaceuticals Inc Price (USD)|PhaseBio Pharmaceuticals Inc Total Return Price (USD)|PhaseBio Pharmaceuticals Inc Enterprise Value (USD)|PhaseBio Pharmaceuticals Inc 30-Day Average Daily Volume|PhaseBio Pharmaceuticals Inc 1 Year Price Returns (Daily)
usamicro_0048|PHAS|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
usamicro_0048|PHAS||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
usamicro_0048|PHAS||5|5|101.333333333|101.333333333|0|101.333333333|0|101.333333333|101.333333333|101.333333333|0|101.333333333|101.333333333|101.333333333|1.44011976048|91.5|1.43913043478|91.1666666667|1.44011976048|0|1.43913043478|0|91.3333333333|1.45078740157|91.6666666667|15.2173913043|101.333333333|101.333333333|101.333333333|91.6666666667|0|30.5|30.4545454545|91.6666666667|30.5|91.2727272727|114|91.2727272727|35.3157894737|0|101.333333333|91.6666666667|91.3333333333|91.2727272727|91.375|0|91.6666666667|91.375|91.6666666667|0|91.3333333333|0|91.2727272727|91.2727272727|91.2727272727|91.2727272727|1.45078740157|1.45078740157|1.44509803922|1.4509394572|1.44747081712
usamicro_0048|PHAS||6|6|9|9|0|9|0|9|9|9|0|9|9|9|334|4|460|6|334|0|460|0|6|508|3|46|9|9|9|3|0|10|11|3|14|11|8|11|19|0|9|3|6|11|8|0|3|8|3|0|6|0|11|11|11|11|508|508|510|479|257
usamicro_0048|PHAS||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
usamicro_0048|PHAS|201709|201709|201709||||||||||||||||||||||||||||||||||12.3923||-0.2066||||||-0.2017|||||||||0.565|-2.56|-2.56|-0.604|||||
usamicro_0048|PHAS|201712|201712|201712|13.766|13.406||0.302||111.515|17.595|93.92||-97.416|-99.065|0.024|||||||||||||0|0.43|0.001|||||||12.3923|18|-0.2046|||19.5884|||-0.2861|||||||||0.628|-2.535|-2.535|-1.095|||||
usamicro_0048|PHAS|201803|201803|201803||||||||||||||||||||||||||||||||||12.3923||-0.3553||||||-0.3426|||||||||0.643|-4.403|-4.403|-1.368|||||
usamicro_0048|PHAS|201806|201806|201806|28.664|28.446||0.276||9.247|5.117|4.13||20.354|-110.142|0.024||||||||||||||0.569|0.015|||||||19.5884||-0.3407|||19.5884|||-0.2817|0|||-16.172|||||0.917|-6.674|-6.674|-1.411|||||
usamicro_0048|PHAS|201809|201809|201809|24.968|24.341||0.251||143.662|7.688|135.974||-116.174|-118.043|0.024|||||||||-0.0646||||0.411|1.576|0.001|||||||19.5884|19|-0.4034|||19.5884||3.2196|-0.2976|0|||-21.513|||0.411||1.056|-7.901|-7.901|-0.83|||||
usamicro_0048|PHAS|201810|201809|201809||||||||||||||||||||||0||0.0171|||||||||||||23.8038||||||||||||||||||5.1|5.1|104.5584||
usamicro_0048|PHAS|201811|201809|201809||||||||||||||||||||||0||0.1132|||||||||||||24.4983||||||||||||||||||2.92|2.92|54.694|120362.8667|
usamicro_0048|PHAS|201812|201812|201812|62.628|61.031||0.355||12.099|4.577|7.522||50.927|-122.911|0.024|||-1.291|0.3517|||1.4864||0.1473|0||0.163|0.233|1.806|0.025|||||||24.4983|24|-0.26|24.4983||24.4983||13.3852|-0.371|-42.974|||-23.846|||0.668||2.241|-4.868|-4.868|0.072|3.1|3.1|59.1037|50104.8333|
usamicro_0048|PHAS|201901|201812|201812|||||||||||||||-2.1612||||1.7799|||0||0.0808|||||||||||||||||||||||||||||||3.3|3.3|27.3134|34638.7|
usamicro_0048|PHAS|201902|201812|201812|||||||||||||||-1.2339||||1.4672|||0||0.0479|||||||||||||||||||||||||||||||3.1589|3.1589|23.8567|16632.2333|
usamicro_0048|PHAS|201903|201903|201903|54.075|51.894||2.279||12.304|3.797|8.507||44.082|-130.204|0.024|||-9.8652|3.3404|||4.3775||0.1648|0||0.5959|0.67|2.058|0.025|||||||24.4984|27|-0.3|24.4984||24.4984||13.8436|-0.3||||-26.736|||0.653||2.316|-7.293|-7.293|0.091|8.66|8.66|169.4044|326750.5667|
usamicro_0048|PHAS|201904|201903|201903|||||||||||||||-14.1487||||8.506|||0||2.2099|||||||||||||28.6229||||||||||||||||||13.75|13.75|330.33|719307.5667|
usamicro_0048|PHAS|201905|201903|201903|||||||||||||||-12.2627||||7.5071|||0||1.6848|||||||||||||28.627||||||||||||||||||11.56|11.56|286.2981|240501.9|
usamicro_0048|PHAS|201906|201906|201906|94.897|90.342||2.509||15.829|5.746|10.083||81.609|-139.436|0.024|146.1781|-10.0998|-13.3172|3.0364|156.412||8.0656||0.1188|0|-23.8638|1.9965|1.18|3.047|0.029|-126.8111||||-181.2792||27.9326|30|-0.33|28.6976||28.6976|0|15.9279|-0.3292|-46.308||-181.2792|-29.294|2.024||0.703||2.404|-9.232|-9.232|0.272|12.42|12.42|310.9173|173408.2667|
usamicro_0048|PHAS|201907|201906|201906|||||||||||||70.8895||-5.2676||93.1081||2.9116|||0||3.1664|||||||||92.7001||||||||||||||||||||||8.28|8.28|156.9681|209759.8667|
usamicro_0048|PHAS|201908|201906|201906|||||||||||||82.6629||-5.0656||103.0031||2.8379|||0||3.7295|||||||||93.0579||||28.6988||||||||||||||||||8.07|8.07|150.9513|110605|
usamicro_0048|PHAS|201909|201909|201909|83.369|81.771||2.802||15.399|5.962|9.437||70.804|-150.827|0.024|25.8135|-1.4598|-1.0592|0.5552|59.4063||1.375||0.1374|0|-74.7673|6.1067|0.583|1.659|0.029|-46.5665||||-124.8933|93.8506|28.7199|32|-0.4|28.7528||28.7528|0|13.8131|-0.4005|0.031||-124.8933|-32.784|1.854||||2.803|-11.391|-11.391|0.185|3.91|3.91|31.5643|181129.9667|
usamicro_0048|PHAS|201910|201909|201909|||||||||||||24.883||-1.3978||58.5515||1.7056|||0||5.9324|||||||1.3782||93.428||||||||||||||||||||||4.2|4.2|48.7208|519856.6333|-19.4118
usamicro_0048|PHAS|201911|201909|201909|||||||||||||11.7245||-0.6071||46.4423||1.3164|||0||6.7368||||||4|1.2271||94.7021||||28.7663||||||||||||||||||3.24|3.24|21.1618|223688.8667|12.8028
usamicro_0048|PHAS|201912|201912|201912|78.823|74.025||3.639||22.516|8.479|14.037||59.978|-162.158|0.024|49.3188|-2.9669|-2.8713|1.4115|71.1202||2.9305||0.2452|0|-27.0299|7.9501|1.233|2.921|0.029|-55.077||7|2.1834|-63.837||28.7769|40|-0.39|28.7664||28.7664|0|8.8758|-0.3897|0||-63.837|-39.247|2.361||1.861||3.663|-11.331|-11.331|-0.042|6.11|6.11|116.4417|576613.2|97.7346
usamicro_0048|PHAS|202001|201912|201912|||||||||||||35.5509||-2.2683||57.967||2.5228|||0||9.8667||||||10|3.9353||91.407||||||||||||||||||||||5.26|5.26|91.9903|865496.5333|50.9091
usamicro_0048|PHAS|202002|201912|201912|||||||||||||26.1692||-1.6087||49.0043||2.0767|||0||9.857||||||9|3.973||91.4736||||||||||||||||||||||4.33|4.33|65.2375|333166.6|33.2742
usamicro_0048|PHAS|202003|202003|202003|72.541|59.441||4.285||23.372|7.495|15.877||53.486|-177.063|0.024|24.9343|-1.0791|-0.9502|0.6579|46.599||1.6315||0.2757|0|-50.0986|9.612|0.896|1.918|0.029|-63.9984||9|2.2926|-75.589|82.6816|28.7733|40|-0.52|28.7806||28.7806|0|8.0503|-0.5044|||-75.589|-46.859|2.028||0.32||3.159|-14.905|-14.905|-0.167|3.31|3.31|50.5668|304164.2|-65.1945
usamicro_0048|PHAS|202004|202003|202003|||||||||||||32.7397||-1.1758||54.342||2.0717|||0||8.4094||||||2|1.7921||76.9532||||28.7806||||||||||||||||||3.74|3.74|62.9424|257565.8667|-70.5344
usamicro_0048|PHAS|202005|202003|202003|||||||||||||63.2529||-1.5034||84.6103||2.4161|||0||6.8813||||||2|2.143||76.903||||28.781||||||||||||||||||4.49|4.49|84.5297|254996.1333|-47.9203
usamicro_0048|PHAS|202006|202006|202006|63.741|53.025||7.012||44.417|17.802|26.615||26.393|-205.205|0.024|46.6082|-1.4372|-1.7116|1.3349|65.2548||5.0302||0.5601|0|-1.4649|10.8621|0|6.967|0.029|-92.3917||3|1.9495|-112.5141|74.9851|28.8052|50|-0.98|28.8616||28.8616||2.9786|-0.852|-0.472||-112.5141|-65.769|||||3.242|-28.142|-28.142|-0.358|4.6|4.6|94.5214|1221574.7333|-64.939
usamicro_0048|PHAS|202007|202006|202006|||||||||||||38.0692||-1.5966||56.7433||4.7897|||0||12.7425||||||2|1.774||74.3328||||||||||||||||||||||4.38|4.38|88.1718|516452.1|-48.7836
usamicro_0048|PHAS|202008|202006|202006|||||||||||||36.9929||-1.3266||54.7573||4.2247|||0||12.6855||||||2|1.7209||73.0666||||29.3429||||||||||||||||||3.8|3.8|73.261|605157.5333|-55.3241
usamicro_0048|PHAS|202009|202009|202009|49.948|39.353||8.202||53.855|11.37|42.485||4.352|-230.348|0.024|31.9288|-0.9703|-1.1566|1.3255|49.7922||3.869|-0.0113|3.0924|0|-3.5854|13.032||2.124|0.029|-140.779||2|1.7528|-184.9214|73.0707|29.2432|50|-0.86|29.3593||29.3593||3.4611|-0.7132|-2.47||-184.9214|-79.521|||||3.076|-25.143|-25.143|-0.359|3.48|3.48|63.8713|247177.4333|-15.8273
usamicro_0048|PHAS|202010|202009|202009|||||||||||||25.9242||-0.9231||43.9051||19.2266|-0.0088||0||12.5409||||||4|1.8893||||||||||||||||||||||||2.85|2.85|57.779|161498.2333|-32.9238
usamicro_0048|PHAS|202011|202009|202009|||||||||||||||-1.2611||||24.0883|-0.0122||||8.9503||||||3|2.2716||74.5497||||29.3648||||||||||||||||||3.57|3.57|78.9373|186004.2333|16.5644
usamicro_0048|PHAS|202012|202012|202012|40.149|28.122||10.151||75.559|14.96|60.599||-25.202|-260.723|0.024||-0.8414|-1.1157|1.6469|||21.9966|-0.0071|-0.4812||-3.4588|8.012||3.674|0.029|-260.997||7|2.0217|-414.1143|75.721|29.4002|50|-1.03|29.4419||29.4419||1.8798|-0.8915|||-414.1143|-98.565|||0.32||3.611|-30.375|-30.375|-0.324|3.26|3.26|69.8342|316419.9667|-45.0082
usamicro_0048|PHAS|202101|202012|202012|||||||||||||||-1.716|||||-0.0082||||7.7914||||||2|1.8949||75.5798||||||||||||||||||||||4.12|4.12|105.3066|361274.4|-24.0631
usamicro_0048|PHAS|202102|202012|202012|||||||||||||||-1.668|||||-0.0082||||10.6809||||||2|1.9486||75.4901||||||||||||||||||||||4.02|4.02|102.3624|360340.5667|-11.0092
usamicro_0048|PHAS|202103|202103|202103|88.157|76.963||12.607||92.41|16.668|75.742||8.411|-288.081|0.024||-0.8985|-2.2731|0.9893||||-0.0072|1.2834||-37.7884|6.7419||5.898|0.048|-416.2717||2|2.2567|-823.0872|91.4481|31.2827|50|-0.87|47.952||47.952||4.6174|-0.8244|-60.536||-823.0872|-111.018|||||3.327|-27.358|-27.358|-0.283|3.25|3.25|139.4964|887931.9|4.5317
usamicro_0048|PHAS|202104|202103|202103|||||||||||||||-1.686||||17.3314|-0.0063||||7.365||||||2|2.37||91.9897||||47.952||||||||||||||||||3.04|3.04|79.6061|668328.0333|-21.5026
usamicro_0048|PHAS|202105|202103|202103|||||||||||||||-1.7571||||17.7304|-0.0071||||8.0056|||||||1.6915||97.6717||||47.952||||||||||||||||||3.11|3.11|82.9627|392937.5|-43.8538
usamicro_0048|PHAS|202106|202106|202106|88.5|64.456||12.08||119.812|16.174|103.638||-19.175|-316.76|0.024||-1.1086|-2.3258|1.2288|||20.9231|-0.0237|-0.4932||-34.5698|7.2807|18.4|2.958|0.048|-1006.8141||1|1.5517||92.1967|47.9859|55|-0.6|48.0278||48.0278||5.1228|-0.5121|0.185|||-111.555|||10.338||4.025|-27.079|-28.679|-0.249|3.67|3.67|109.8158|387308.5|-19.1304
usamicro_0048|PHAS|202107|202106|202106|||||||||||||||-2.3142|||||-0.0224||||7||||||2|1.8188||||||||||||||||||||||||3.51|3.51|113.5786|375906.1667|-15.2174
usamicro_0048|PHAS|202108|202106|202106|||||||||||||||-2.0509|||||-0.0206||||9.6039||||||2|2.1246||||||48.0425||||||||||||||||||3.24|3.24|100.6587|379768.6667|-16.0622
usamicro_0048|PHAS|202109|202109|202109|65.241|56.357||12.427||128.054|21.457|106.597||-50.329|-348.684|0.024||-0.8555|-1.8943|1.3025||||-0.066|-0.1613||-39.4735|4.4123||8.521|0.048|||2|1.8365|||48.0463|60|-0.66|48.0625||48.0625||2.6265|-0.5949|0.015|||-118.336|||0.335||3.845|-31.924|-31.924|-0.218|3.08|3.08|92.9719|343389.4333|-11.396
usamicro_0048|PHAS|202110|202109|202109|||||||||||||||-3.4333|||||-0.0798||||9.764||||||3|1.6634||96.2456||||||||||||||||||||||3.85|3.85|136.8006|463565.4|29.6552
usamicro_0048|PHAS|202111|202109|202109|||||||||||||||-1.2997|||||-0.0441||||10.0594||||||6|0.9389||93.0197||||48.09||||||||||||||||||2.08|2.08|51.7872|851689.6333|-45.2632
usamicro_0048|PHAS|202112|202112|202112|||||||||||||||-1.9515|||||-0.0554||||9.7439||||||2|1.6356||92.6089||||||||||||||||||||||2.62|2.62|77.7558|641615.6667|-22.3214
usamicro_0048|PHAS|202201|202112|202112|||||||||||||||-1.3239|||||-0.0425||||9.3039||||||3|2.5103||88.2436||||||||||||||||||||||2.1|2.1|52.749|250035.1|-48.0519
usamicro_0048|PHAS|202202|202112|202112|||||||||||||||-0.6359|||||-0.0325|||||||||||||||||||||||||||||||||||1.53|1.53|25.3377|256212.7667|-69.2153